FierceBiotech | Nachrichten

Zeit	Aktuelle Nachrichten
Do	Propeller Health links up with Orion to expand its digital inhaler footprint in Europe
Do	How understanding organ growth in fruit flies sheds light on genetic diseases
Do	Enzyvant finds new CEO in former Alexion executive Rachelle Jacques
Do	Merck moves to buy Immune Design and its cancer vaccines platform for $300M
Do	MPM Capital secures $400M treasure chest for early biotechs
Do	Morphic bags J&J as second big pharma partner for oral integrins
Do	Qiagen links with Ares Genetics in push for new bioinformatics and assay solutions
Do	WuXiAppTec CDMO STA Pharma inks exclusive deal with Swiss biotech BioLingus
Mi	Clinerion and Citeline team to streamline and improve decisionmaking for trials
Mi	Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson's disease
Mi	Using Bristol-Myers' popular leukemia drug to improve anti-PD-1 cancer immunotherapy
Mi	Medtronic launches 'brain pacemaker' implant for reducing epileptic seizures
Mi	Turbulent times for Xencor as FDA slaps hold on AML bispecific
Mi	Intuitive Surgical receives FDA clearance for its lung cancer biopsy robot
Mi	Pluristem's cell therapies head for orbit with NASA deal
Mi	Vical stops antifungal trial, lays off staff to eke out cash
Mi	MorphoSys CEO Simon Moroney announces his retirement
Mi	Novo Nordisk to make its digital insulin pens compatible with Abbott, Glooko and more
Mi	FDA clears Hygieia's 'GPS for insulin' diabetes management app
Mi	Darrin Disley takes CEO role at cell therapy startup
Di	With positive phase 3, Intercept to file NASH drug for approval while Inventiva faces a setback
Di	Pfizer and Lilly's NGF painkiller moves forward, meeting phase 3 endpoints in lower back pain
Di	End of the line looms for Aradigm as it files for bankruptcy
Di	Arix reappoints CEO 5 months after starting hunt for replacement
Di	Realm set to offload assets, leave London following failures

Zeit

Aktuelle Nachrichten

Propeller Health links up with Orion to expand its digital inhaler footprint in Europe

How understanding organ growth in fruit flies sheds light on genetic diseases

Enzyvant finds new CEO in former Alexion executive Rachelle Jacques

Merck moves to buy Immune Design and its cancer vaccines platform for $300M

MPM Capital secures $400M treasure chest for early biotechs

Morphic bags J&J as second big pharma partner for oral integrins

Qiagen links with Ares Genetics in push for new bioinformatics and assay solutions

WuXiAppTec CDMO STA Pharma inks exclusive deal with Swiss biotech BioLingus

Clinerion and Citeline team to streamline and improve decisionmaking for trials

Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson's disease

Using Bristol-Myers' popular leukemia drug to improve anti-PD-1 cancer immunotherapy

Medtronic launches 'brain pacemaker' implant for reducing epileptic seizures

Turbulent times for Xencor as FDA slaps hold on AML bispecific

Intuitive Surgical receives FDA clearance for its lung cancer biopsy robot

Pluristem's cell therapies head for orbit with NASA deal

Vical stops antifungal trial, lays off staff to eke out cash

MorphoSys CEO Simon Moroney announces his retirement

Novo Nordisk to make its digital insulin pens compatible with Abbott, Glooko and more

FDA clears Hygieia's 'GPS for insulin' diabetes management app

Darrin Disley takes CEO role at cell therapy startup

With positive phase 3, Intercept to file NASH drug for approval while Inventiva faces a setback

Pfizer and Lilly's NGF painkiller moves forward, meeting phase 3 endpoints in lower back pain

End of the line looms for Aradigm as it files for bankruptcy

Arix reappoints CEO 5 months after starting hunt for replacement

Realm set to offload assets, leave London following failures

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FierceBiotech